ConductScience.org, home

Trial · NCT05702944

The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma

NCT05702944, Phase 4, Recruiting, Seoul National University Hospital

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma. Trials, record NCT05702944. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05702944

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
The Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma
NCT number
NCT05702944
Status
Recruiting
Phases
Phase 4
Enrollment
24 participants, estimated
Lead sponsor
Seoul National University Hospital
Conditions
Pheochromocytoma, Paraganglioma, Adrenalectomy; Status, Adrenergics Causing Adverse Effects in Therapeutic Use
Interventions
Phenoxybenzamine
First posted
2023-01-27
Last updated
2025-06-12

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryThe effect and safety of omitting preoperative alpha blockade during surgeryduring surgeryPercentage of time during the surgery with systolic blood pressure \> 160mmHg or average blood pressure \< 60mmHg
SecondaryThe effect and safety of omitting preoperative alpha blockade during surgeryduring surgery
1. Percentage of the surgery time greater than 100 times per pulse minute 2. Average systolic/diastolic blood pressure in millimeters of mercury and pulse in beats each minutes during surgery 3. Types and amount of antihypertensive drugs in mg per day during surgery 4. Types and amount of vasopressor drugs in mg per day during surgery
SecondaryThe effect and safety of omitting preoperative alpha blockade before surgery3 days, 2 days, 1 day before surgery
1. The number of times systolic blood pressure more than 130 mmHg and diastolic blood pressure more than 80mmHg in the preoperative ward 2. The number of times of pulse rate per minute more than 80 times in the preoperative ward
SecondaryThe effect and safety of omitting preoperative alpha blockade after surgery1 day, 2 day, 2 weeks, 3 months after surgery
1. The number of times of average blood pressure less than 60mmHg in postoperative ward 2. Average blood pressure in postoperative ward 3. Types and amount of antihypertensive drugs in mg per day after surgery 4. Types and amount of vasopressor drugs in mg per day after surgery

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers15

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
3042392BACKGROUNDPubMed
3179962BACKGROUNDPubMed
3776697BACKGROUNDPubMed
10678269BACKGROUNDPubMed
16112304BACKGROUNDPubMed
17989126BACKGROUNDPubMed
19497985BACKGROUNDPubMed
19965926BACKGROUNDPubMed
20664475BACKGROUNDPubMed
22025238BACKGROUNDPubMed

1 to 10 of 15

See all 15 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT05702944

GET https://conductscience.org/api/trials/v1/NCT05702944/registered